258 related articles for article (PubMed ID: 28030591)
21. Proteolysis of α-synuclein fibrils in the lysosomal pathway limits induction of inclusion pathology.
Sacino AN; Brooks MM; Chakrabarty P; Saha K; Khoshbouei H; Golde TE; Giasson BI
J Neurochem; 2017 Feb; 140(4):662-678. PubMed ID: 27424880
[TBL] [Abstract][Full Text] [Related]
22. Quaternary structure of patient-homogenate amplified α-synuclein fibrils modulates seeding of endogenous α-synuclein.
Frieg B; Geraets JA; Strohäker T; Dienemann C; Mavroeidi P; Jung BC; Kim WS; Lee SJ; Xilouri M; Zweckstetter M; Schröder GF
Commun Biol; 2022 Sep; 5(1):1040. PubMed ID: 36180728
[TBL] [Abstract][Full Text] [Related]
23. Unique copper-induced oligomers mediate alpha-synuclein toxicity.
Wright JA; Wang X; Brown DR
FASEB J; 2009 Aug; 23(8):2384-93. PubMed ID: 19325037
[TBL] [Abstract][Full Text] [Related]
24. Haploinsufficiency of cathepsin D leads to lysosomal dysfunction and promotes cell-to-cell transmission of α-synuclein aggregates.
Bae EJ; Yang NY; Lee C; Kim S; Lee HJ; Lee SJ
Cell Death Dis; 2015 Oct; 6(10):e1901. PubMed ID: 26448324
[TBL] [Abstract][Full Text] [Related]
25. α-Synuclein (αSyn) Preformed Fibrils Induce Endogenous αSyn Aggregation, Compromise Synaptic Activity and Enhance Synapse Loss in Cultured Excitatory Hippocampal Neurons.
Wu Q; Takano H; Riddle DM; Trojanowski JQ; Coulter DA; Lee VM
J Neurosci; 2019 Jun; 39(26):5080-5094. PubMed ID: 31036761
[TBL] [Abstract][Full Text] [Related]
26. Off-pathway α-synuclein oligomers seem to alter α-synuclein turnover in a cell model but lack seeding capability in vivo.
Fagerqvist T; Näsström T; Ihse E; Lindström V; Sahlin C; Tucker SM; Kasaryan A; Karlsson M; Nikolajeff F; Schell H; Outeiro TF; Kahle PJ; Lannfelt L; Ingelsson M; Bergström J
Amyloid; 2013 Dec; 20(4):233-44. PubMed ID: 24053224
[TBL] [Abstract][Full Text] [Related]
27. Extracellular aggregated alpha synuclein primarily triggers lysosomal dysfunction in neural cells prevented by trehalose.
Hoffmann AC; Minakaki G; Menges S; Salvi R; Savitskiy S; Kazman A; Vicente Miranda H; Mielenz D; Klucken J; Winkler J; Xiang W
Sci Rep; 2019 Jan; 9(1):544. PubMed ID: 30679445
[TBL] [Abstract][Full Text] [Related]
28. α-synuclein oligomers and fibrils: a spectrum of species, a spectrum of toxicities.
Alam P; Bousset L; Melki R; Otzen DE
J Neurochem; 2019 Sep; 150(5):522-534. PubMed ID: 31254394
[TBL] [Abstract][Full Text] [Related]
29. Raised calcium promotes α-synuclein aggregate formation.
Nath S; Goodwin J; Engelborghs Y; Pountney DL
Mol Cell Neurosci; 2011 Feb; 46(2):516-26. PubMed ID: 21145971
[TBL] [Abstract][Full Text] [Related]
30. Impact of α-Synuclein Fibrillar Strains and β-Amyloid Assemblies on Mouse Cortical Neurons Endo-Lysosomal Logistics.
Chou QL; Alik A; Marquier F; Melki R; Treussart F; Simonneau M
eNeuro; 2022; 9(3):. PubMed ID: 35470226
[TBL] [Abstract][Full Text] [Related]
31. Dopamine facilitates alpha-synuclein oligomerization in human neuroblastoma SH-SY5Y cells.
Yamakawa K; Izumi Y; Takeuchi H; Yamamoto N; Kume T; Akaike A; Takahashi R; Shimohama S; Sawada H
Biochem Biophys Res Commun; 2010 Jan; 391(1):129-34. PubMed ID: 19900407
[TBL] [Abstract][Full Text] [Related]
32. Autophagy modulates SNCA/α-synuclein release, thereby generating a hostile microenvironment.
Poehler AM; Xiang W; Spitzer P; May VE; Meixner H; Rockenstein E; Chutna O; Outeiro TF; Winkler J; Masliah E; Klucken J
Autophagy; 2014; 10(12):2171-92. PubMed ID: 25484190
[TBL] [Abstract][Full Text] [Related]
33. Lysosomal exocytosis releases pathogenic α-synuclein species from neurons in synucleinopathy models.
Xie YX; Naseri NN; Fels J; Kharel P; Na Y; Lane D; Burré J; Sharma M
Nat Commun; 2022 Aug; 13(1):4918. PubMed ID: 35995799
[TBL] [Abstract][Full Text] [Related]
34. α-Synuclein-Confocal Nanoscanning (ASYN-CONA), a Bead-Based Assay for Detecting Early-Stage α-Synuclein Aggregation.
Pérez-Pi I; Evans DA; Horrocks MH; Pham NT; Dolt KS; Koszela J; Kunath T; Auer M
Anal Chem; 2019 May; 91(9):5582-5590. PubMed ID: 30964656
[TBL] [Abstract][Full Text] [Related]
35. Structural and functional properties of prefibrillar α-synuclein oligomers.
Pieri L; Madiona K; Melki R
Sci Rep; 2016 Apr; 6():24526. PubMed ID: 27075649
[TBL] [Abstract][Full Text] [Related]
36. Lysosomal pathology associated with alpha-synuclein accumulation in transgenic models using an eGFP fusion protein.
Rockenstein E; Schwach G; Ingolic E; Adame A; Crews L; Mante M; Pfragner R; Schreiner E; Windisch M; Masliah E
J Neurosci Res; 2005 Apr; 80(2):247-59. PubMed ID: 15765523
[TBL] [Abstract][Full Text] [Related]
37. Structure, function and toxicity of alpha-synuclein: the Bermuda triangle in synucleinopathies.
Villar-Piqué A; Lopes da Fonseca T; Outeiro TF
J Neurochem; 2016 Oct; 139 Suppl 1():240-255. PubMed ID: 26190401
[TBL] [Abstract][Full Text] [Related]
38. Oxidative stress-induced posttranslational modifications of alpha-synuclein: specific modification of alpha-synuclein by 4-hydroxy-2-nonenal increases dopaminergic toxicity.
Xiang W; Schlachetzki JC; Helling S; Bussmann JC; Berlinghof M; Schäffer TE; Marcus K; Winkler J; Klucken J; Becker CM
Mol Cell Neurosci; 2013 May; 54():71-83. PubMed ID: 23369945
[TBL] [Abstract][Full Text] [Related]
39. Phosphorylation does not prompt, nor prevent, the formation of alpha-synuclein toxic species in a rat model of Parkinson's disease.
Azeredo da Silveira S; Schneider BL; Cifuentes-Diaz C; Sage D; Abbas-Terki T; Iwatsubo T; Unser M; Aebischer P
Hum Mol Genet; 2009 Mar; 18(5):872-87. PubMed ID: 19074459
[TBL] [Abstract][Full Text] [Related]
40. Impact of high cholesterol in a Parkinson's disease model: Prevention of lysosomal leakage versus stimulation of α-synuclein aggregation.
Eriksson I; Nath S; Bornefall P; Giraldo AM; Öllinger K
Eur J Cell Biol; 2017 Mar; 96(2):99-109. PubMed ID: 28109635
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
